Amsterdam institute for Immunology and Infectious diseases
AI&I news
Treating sepsis: act fast and know when to stopSepsis is a medical emergency, but once the acute crisis is over, the question changes: how much treatment does this patient still need? Today, in the second article of our series ahead of World Sepsis Day on 13 September, Dr. Kim Sigaloff outlines why the smartest course of antibiotics may be the shortest one that is still safe.
What is sepsis? When the body's defence turns against itselfIn the run-up to World Sepsis Day on 13 September, we are publishing a series of three articles on sepsis. In this first article, PhD candidates Aryna Kolodyazhna, Floris de Vries and Susanne Doeleman explain what sepsis is, why it can become life-threatening within hours, and how their research at Amsterdam UMC and the Amsterdam Institute for Immunology and Infectious Diseases (AI&I) helps us better understand the body's response to infection.
Work Visit Grant / Annemiek Dijkhuis Gains New Expertise in FranceAI&I is committed to supporting innovative research and fostering international collaboration. In 2025, after 17 years at the Experimental Immunology lab, the AI&I International Work Visit Grant enabled research technician Annemiek Dijkhuis to spend two months at the lab of Dr. Aurélien Justet at the Centre Hospitalier Universitaire (CHU) in Caen, France. For two months Annemiek was emerged in a new research environment, gaining hands-on expertise in generating Precision Cut Lung Slices (PCLS) and performing single-cell RNA sequencing on these slices.
